WELLINGTON TRUST COMPANY, NA has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan WTC-CIF BIOTECHNOLOGY PORTFOLIO
| Measure | Date | Value |
|---|
| 2023 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2023 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-08-31 | $5,288,820 |
| Total unrealized appreciation/depreciation of assets | 2023-08-31 | $5,288,820 |
| Total transfer of assets to this plan | 2023-08-31 | $4,511,212 |
| Total transfer of assets from this plan | 2023-08-31 | $7,916,342 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-08-31 | $27,629 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-08-31 | $272,697 |
| Total income from all sources (including contributions) | 2023-08-31 | $9,725,891 |
| Total loss/gain on sale of assets | 2023-08-31 | $4,319,673 |
| Total of all expenses incurred | 2023-08-31 | $46,493 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-08-31 | $0 |
| Value of total assets at end of year | 2023-08-31 | $86,573,974 |
| Value of total assets at beginning of year | 2023-08-31 | $80,544,774 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-08-31 | $46,493 |
| Total interest from all sources | 2023-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-08-31 | $88,379 |
| Administrative expenses professional fees incurred | 2023-08-31 | $46,493 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-08-31 | $149,063 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-08-31 | $348,356 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-08-31 | $27,629 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-08-31 | $272,697 |
| Other income not declared elsewhere | 2023-08-31 | $3,915 |
| Total non interest bearing cash at end of year | 2023-08-31 | $20 |
| Total non interest bearing cash at beginning of year | 2023-08-31 | $0 |
| Value of net income/loss | 2023-08-31 | $9,679,398 |
| Value of net assets at end of year (total assets less liabilities) | 2023-08-31 | $86,546,345 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-08-31 | $80,272,077 |
| Value of interest in common/collective trusts at end of year | 2023-08-31 | $41,780 |
| Value of interest in common/collective trusts at beginning of year | 2023-08-31 | $1,493,864 |
| Net investment gain or loss from common/collective trusts | 2023-08-31 | $25,104 |
| Income. Dividends from common stock | 2023-08-31 | $88,379 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-08-31 | $86,383,111 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-08-31 | $78,702,554 |
| Aggregate proceeds on sale of assets | 2023-08-31 | $49,848,171 |
| Aggregate carrying amount (costs) on sale of assets | 2023-08-31 | $45,528,498 |
| 2022 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-09-01 | $5,288,820 |
| Total unrealized appreciation/depreciation of assets | 2022-09-01 | $5,288,820 |
| Total transfer of assets to this plan | 2022-09-01 | $4,511,212 |
| Total transfer of assets from this plan | 2022-09-01 | $7,916,342 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-09-01 | $27,629 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-09-01 | $272,697 |
| Total income from all sources (including contributions) | 2022-09-01 | $9,725,891 |
| Total loss/gain on sale of assets | 2022-09-01 | $4,319,673 |
| Total of all expenses incurred | 2022-09-01 | $46,493 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-09-01 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-09-01 | $0 |
| Value of total assets at end of year | 2022-09-01 | $86,573,974 |
| Value of total assets at beginning of year | 2022-09-01 | $80,544,774 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-09-01 | $46,493 |
| Total interest from all sources | 2022-09-01 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-09-01 | $88,379 |
| Administrative expenses professional fees incurred | 2022-09-01 | $46,493 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-09-01 | $149,063 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-09-01 | $348,356 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-09-01 | $27,629 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-09-01 | $272,697 |
| Other income not declared elsewhere | 2022-09-01 | $3,915 |
| Total non interest bearing cash at end of year | 2022-09-01 | $20 |
| Total non interest bearing cash at beginning of year | 2022-09-01 | $0 |
| Value of net income/loss | 2022-09-01 | $9,679,398 |
| Value of net assets at end of year (total assets less liabilities) | 2022-09-01 | $86,546,345 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-09-01 | $80,272,077 |
| Value of interest in common/collective trusts at end of year | 2022-09-01 | $41,780 |
| Value of interest in common/collective trusts at beginning of year | 2022-09-01 | $1,493,864 |
| Net investment gain or loss from common/collective trusts | 2022-09-01 | $25,104 |
| Income. Dividends from common stock | 2022-09-01 | $88,379 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-09-01 | $86,383,111 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-09-01 | $78,702,554 |
| Aggregate proceeds on sale of assets | 2022-09-01 | $49,848,171 |
| Aggregate carrying amount (costs) on sale of assets | 2022-09-01 | $45,528,498 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-08-31 | $-12,107,898 |
| Total unrealized appreciation/depreciation of assets | 2022-08-31 | $-12,107,898 |
| Total transfer of assets to this plan | 2022-08-31 | $5,561,797 |
| Total transfer of assets from this plan | 2022-08-31 | $13,543,973 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-08-31 | $272,697 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-08-31 | $38,548 |
| Total income from all sources (including contributions) | 2022-08-31 | $-24,980,749 |
| Total loss/gain on sale of assets | 2022-08-31 | $-13,230,455 |
| Total of all expenses incurred | 2022-08-31 | $40,381 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-08-31 | $0 |
| Value of total assets at end of year | 2022-08-31 | $80,544,774 |
| Value of total assets at beginning of year | 2022-08-31 | $113,313,931 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-08-31 | $40,381 |
| Total interest from all sources | 2022-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-08-31 | $347,732 |
| Administrative expenses professional fees incurred | 2022-08-31 | $40,381 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-08-31 | $348,356 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-08-31 | $327,947 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-08-31 | $272,697 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-08-31 | $38,548 |
| Total non interest bearing cash at end of year | 2022-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2022-08-31 | $98,060 |
| Value of net income/loss | 2022-08-31 | $-25,021,130 |
| Value of net assets at end of year (total assets less liabilities) | 2022-08-31 | $80,272,077 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-08-31 | $113,275,383 |
| Value of interest in common/collective trusts at end of year | 2022-08-31 | $1,493,864 |
| Value of interest in common/collective trusts at beginning of year | 2022-08-31 | $8,332,209 |
| Net investment gain or loss from common/collective trusts | 2022-08-31 | $9,872 |
| Income. Dividends from common stock | 2022-08-31 | $347,732 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-08-31 | $78,702,554 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-08-31 | $104,555,715 |
| Aggregate proceeds on sale of assets | 2022-08-31 | $84,511,743 |
| Aggregate carrying amount (costs) on sale of assets | 2022-08-31 | $97,742,198 |
| 2021 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-08-31 | $-15,505,120 |
| Total unrealized appreciation/depreciation of assets | 2021-08-31 | $-15,505,120 |
| Total transfer of assets to this plan | 2021-08-31 | $13,527,628 |
| Total transfer of assets from this plan | 2021-08-31 | $101,060,809 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-08-31 | $38,548 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-08-31 | $1,104,532 |
| Total income from all sources (including contributions) | 2021-08-31 | $11,199,528 |
| Total loss/gain on sale of assets | 2021-08-31 | $26,308,063 |
| Total of all expenses incurred | 2021-08-31 | $48,009 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-08-31 | $0 |
| Value of total assets at end of year | 2021-08-31 | $113,313,931 |
| Value of total assets at beginning of year | 2021-08-31 | $190,761,577 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-08-31 | $48,009 |
| Total interest from all sources | 2021-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-08-31 | $390,811 |
| Administrative expenses professional fees incurred | 2021-08-31 | $48,009 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-08-31 | $327,947 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-08-31 | $471,096 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-08-31 | $38,548 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-08-31 | $1,104,532 |
| Total non interest bearing cash at end of year | 2021-08-31 | $98,060 |
| Total non interest bearing cash at beginning of year | 2021-08-31 | $99,759 |
| Value of net income/loss | 2021-08-31 | $11,151,519 |
| Value of net assets at end of year (total assets less liabilities) | 2021-08-31 | $113,275,383 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-08-31 | $189,657,045 |
| Value of interest in common/collective trusts at end of year | 2021-08-31 | $8,332,209 |
| Value of interest in common/collective trusts at beginning of year | 2021-08-31 | $8,485,968 |
| Net investment gain or loss from common/collective trusts | 2021-08-31 | $5,774 |
| Income. Dividends from common stock | 2021-08-31 | $390,811 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2021-08-31 | $104,555,715 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-08-31 | $181,704,754 |
| Aggregate proceeds on sale of assets | 2021-08-31 | $197,765,841 |
| Aggregate carrying amount (costs) on sale of assets | 2021-08-31 | $171,457,778 |
| 2020 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-08-31 | $28,533,538 |
| Total unrealized appreciation/depreciation of assets | 2020-08-31 | $28,533,538 |
| Total transfer of assets to this plan | 2020-08-31 | $35,243,140 |
| Total transfer of assets from this plan | 2020-08-31 | $20,737,571 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-08-31 | $1,104,532 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-08-31 | $108,094 |
| Total income from all sources (including contributions) | 2020-08-31 | $41,208,476 |
| Total loss/gain on sale of assets | 2020-08-31 | $11,311,884 |
| Total of all expenses incurred | 2020-08-31 | $44,776 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-08-31 | $0 |
| Value of total assets at end of year | 2020-08-31 | $190,761,577 |
| Value of total assets at beginning of year | 2020-08-31 | $134,095,870 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-08-31 | $44,776 |
| Total interest from all sources | 2020-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-08-31 | $1,285,932 |
| Administrative expenses professional fees incurred | 2020-08-31 | $44,776 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-08-31 | $471,096 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-08-31 | $198,976 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-08-31 | $1,104,532 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-08-31 | $108,094 |
| Total non interest bearing cash at end of year | 2020-08-31 | $99,759 |
| Total non interest bearing cash at beginning of year | 2020-08-31 | $0 |
| Value of net income/loss | 2020-08-31 | $41,163,700 |
| Value of net assets at end of year (total assets less liabilities) | 2020-08-31 | $189,657,045 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-08-31 | $133,987,776 |
| Value of interest in common/collective trusts at end of year | 2020-08-31 | $8,485,968 |
| Value of interest in common/collective trusts at beginning of year | 2020-08-31 | $12,339,982 |
| Net investment gain or loss from common/collective trusts | 2020-08-31 | $77,122 |
| Income. Dividends from common stock | 2020-08-31 | $1,285,932 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-08-31 | $181,704,754 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-08-31 | $121,556,912 |
| Aggregate proceeds on sale of assets | 2020-08-31 | $102,901,910 |
| Aggregate carrying amount (costs) on sale of assets | 2020-08-31 | $91,590,026 |
| 2019 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2019 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-08-31 | $-38,581,184 |
| Total unrealized appreciation/depreciation of assets | 2019-08-31 | $-38,581,184 |
| Total transfer of assets to this plan | 2019-08-31 | $9,742,464 |
| Total transfer of assets from this plan | 2019-08-31 | $64,189,232 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-08-31 | $108,094 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-08-31 | $32,593 |
| Total income from all sources (including contributions) | 2019-08-31 | $-28,390,711 |
| Total loss/gain on sale of assets | 2019-08-31 | $9,487,312 |
| Total of all expenses incurred | 2019-08-31 | $45,767 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-08-31 | $0 |
| Value of total assets at end of year | 2019-08-31 | $134,095,870 |
| Value of total assets at beginning of year | 2019-08-31 | $216,903,615 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-08-31 | $45,767 |
| Total interest from all sources | 2019-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-08-31 | $459,207 |
| Administrative expenses professional fees incurred | 2019-08-31 | $45,767 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-08-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-08-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2019-08-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-08-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-08-31 | $198,976 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-08-31 | $1,150,393 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-08-31 | $108,094 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-08-31 | $32,593 |
| Total non interest bearing cash at end of year | 2019-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2019-08-31 | $0 |
| Value of net income/loss | 2019-08-31 | $-28,436,478 |
| Value of net assets at end of year (total assets less liabilities) | 2019-08-31 | $133,987,776 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-08-31 | $216,871,022 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-08-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-08-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2019-08-31 | $12,339,982 |
| Value of interest in common/collective trusts at beginning of year | 2019-08-31 | $5,969,191 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-08-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-08-31 | $0 |
| Asset value of US Government securities at end of year | 2019-08-31 | $0 |
| Asset value of US Government securities at beginning of year | 2019-08-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-08-31 | $243,954 |
| Income. Dividends from common stock | 2019-08-31 | $459,207 |
| Asset. Corporate debt instrument debt (other) at end of year | 2019-08-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2019-08-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-08-31 | $121,556,912 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-08-31 | $209,784,031 |
| Aggregate proceeds on sale of assets | 2019-08-31 | $113,231,685 |
| Aggregate carrying amount (costs) on sale of assets | 2019-08-31 | $103,744,373 |
| 2018 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2018 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2018-08-31 | $2,802,103 |
| Total unrealized appreciation/depreciation of assets | 2018-08-31 | $2,802,103 |
| Total transfer of assets to this plan | 2018-08-31 | $16,916,758 |
| Total transfer of assets from this plan | 2018-08-31 | $34,128,288 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-08-31 | $32,593 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-08-31 | $133,744 |
| Total income from all sources (including contributions) | 2018-08-31 | $13,113,870 |
| Total loss/gain on sale of assets | 2018-08-31 | $9,758,877 |
| Total of all expenses incurred | 2018-08-31 | $54,209 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-08-31 | $0 |
| Value of total assets at end of year | 2018-08-31 | $216,903,615 |
| Value of total assets at beginning of year | 2018-08-31 | $221,156,635 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-08-31 | $54,209 |
| Total interest from all sources | 2018-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-08-31 | $400,350 |
| Administrative expenses professional fees incurred | 2018-08-31 | $54,209 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2018-08-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2018-08-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2018-08-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2018-08-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-08-31 | $1,150,393 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-08-31 | $148,458 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2018-08-31 | $32,593 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2018-08-31 | $133,744 |
| Total non interest bearing cash at end of year | 2018-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2018-08-31 | $36,672 |
| Value of net income/loss | 2018-08-31 | $13,059,661 |
| Value of net assets at end of year (total assets less liabilities) | 2018-08-31 | $216,871,022 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-08-31 | $221,022,891 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-08-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-08-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2018-08-31 | $5,969,191 |
| Value of interest in common/collective trusts at beginning of year | 2018-08-31 | $10,915,829 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-08-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-08-31 | $0 |
| Asset value of US Government securities at end of year | 2018-08-31 | $0 |
| Asset value of US Government securities at beginning of year | 2018-08-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2018-08-31 | $152,540 |
| Income. Dividends from common stock | 2018-08-31 | $400,350 |
| Asset. Corporate debt instrument debt (other) at end of year | 2018-08-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2018-08-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2018-08-31 | $209,784,031 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-08-31 | $210,055,676 |
| Aggregate proceeds on sale of assets | 2018-08-31 | $67,241,495 |
| Aggregate carrying amount (costs) on sale of assets | 2018-08-31 | $57,482,618 |
| 2017 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2017 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2017-08-31 | $54,335,598 |
| Total unrealized appreciation/depreciation of assets | 2017-08-31 | $54,335,598 |
| Total transfer of assets to this plan | 2017-08-31 | $13,660,621 |
| Total transfer of assets from this plan | 2017-08-31 | $23,974,374 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-08-31 | $133,744 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-08-31 | $435,058 |
| Total income from all sources (including contributions) | 2017-08-31 | $63,970,746 |
| Total loss/gain on sale of assets | 2017-08-31 | $9,070,645 |
| Total of all expenses incurred | 2017-08-31 | $53,674 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-08-31 | $0 |
| Value of total assets at end of year | 2017-08-31 | $221,156,635 |
| Value of total assets at beginning of year | 2017-08-31 | $167,854,630 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-08-31 | $53,674 |
| Total interest from all sources | 2017-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2017-08-31 | $488,351 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2017-08-31 | $0 |
| Administrative expenses professional fees incurred | 2017-08-31 | $53,674 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2017-08-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2017-08-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2017-08-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2017-08-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-08-31 | $148,458 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-08-31 | $203,417 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2017-08-31 | $133,744 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2017-08-31 | $435,058 |
| Other income not declared elsewhere | 2017-08-31 | $0 |
| Total non interest bearing cash at end of year | 2017-08-31 | $36,672 |
| Total non interest bearing cash at beginning of year | 2017-08-31 | $0 |
| Value of net income/loss | 2017-08-31 | $63,917,072 |
| Value of net assets at end of year (total assets less liabilities) | 2017-08-31 | $221,022,891 |
| Value of net assets at beginning of year (total assets less liabilities) | 2017-08-31 | $167,419,572 |
| Investment advisory and management fees | 2017-08-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-08-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-08-31 | $0 |
| Interest earned on other investments | 2017-08-31 | $0 |
| Income. Interest from US Government securities | 2017-08-31 | $0 |
| Income. Interest from corporate debt instruments | 2017-08-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2017-08-31 | $10,915,829 |
| Value of interest in common/collective trusts at beginning of year | 2017-08-31 | $6,585,537 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-08-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-08-31 | $0 |
| Asset value of US Government securities at end of year | 2017-08-31 | $0 |
| Asset value of US Government securities at beginning of year | 2017-08-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2017-08-31 | $76,152 |
| Income. Dividends from preferred stock | 2017-08-31 | $0 |
| Income. Dividends from common stock | 2017-08-31 | $488,351 |
| Asset. Corporate debt instrument debt (other) at end of year | 2017-08-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2017-08-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2017-08-31 | $210,055,676 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2017-08-31 | $161,065,676 |
| Aggregate proceeds on sale of assets | 2017-08-31 | $81,089,847 |
| Aggregate carrying amount (costs) on sale of assets | 2017-08-31 | $72,019,202 |
| 2016 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2016 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2016-08-31 | $-21,807,137 |
| Total unrealized appreciation/depreciation of assets | 2016-08-31 | $-21,807,137 |
| Total transfer of assets to this plan | 2016-08-31 | $8,168,060 |
| Total transfer of assets from this plan | 2016-08-31 | $19,596,563 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-08-31 | $435,058 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-08-31 | $28,254 |
| Total income from all sources (including contributions) | 2016-08-31 | $-28,955,691 |
| Total loss/gain on sale of assets | 2016-08-31 | $-7,967,858 |
| Total of all expenses incurred | 2016-08-31 | $53,936 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-08-31 | $0 |
| Value of total assets at end of year | 2016-08-31 | $167,854,630 |
| Value of total assets at beginning of year | 2016-08-31 | $207,885,956 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-08-31 | $53,936 |
| Total interest from all sources | 2016-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2016-08-31 | $779,410 |
| Administrative expenses professional fees incurred | 2016-08-31 | $53,936 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2016-08-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2016-08-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2016-08-31 | $203,417 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2016-08-31 | $110,976 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2016-08-31 | $435,058 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2016-08-31 | $28,254 |
| Total non interest bearing cash at end of year | 2016-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2016-08-31 | $0 |
| Value of net income/loss | 2016-08-31 | $-29,009,627 |
| Value of net assets at end of year (total assets less liabilities) | 2016-08-31 | $167,419,572 |
| Value of net assets at beginning of year (total assets less liabilities) | 2016-08-31 | $207,857,702 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-08-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2016-08-31 | $6,585,537 |
| Value of interest in common/collective trusts at beginning of year | 2016-08-31 | $18,735,903 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-08-31 | $0 |
| Asset value of US Government securities at end of year | 2016-08-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2016-08-31 | $39,894 |
| Income. Dividends from common stock | 2016-08-31 | $779,410 |
| Asset. Corporate debt instrument debt (other) at end of year | 2016-08-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2016-08-31 | $161,065,676 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2016-08-31 | $189,039,077 |
| Aggregate proceeds on sale of assets | 2016-08-31 | $48,693,066 |
| Aggregate carrying amount (costs) on sale of assets | 2016-08-31 | $56,660,924 |
| 2015 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2015 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2015-08-31 | $39,141,706 |
| Total unrealized appreciation/depreciation of assets | 2015-08-31 | $39,141,706 |
| Total transfer of assets to this plan | 2015-08-31 | $20,182,279 |
| Total transfer of assets from this plan | 2015-08-31 | $9,463,067 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-08-31 | $28,254 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-08-31 | $26,598 |
| Total income from all sources (including contributions) | 2015-08-31 | $52,998,857 |
| Total loss/gain on sale of assets | 2015-08-31 | $13,347,722 |
| Total of all expenses incurred | 2015-08-31 | $48,490 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-08-31 | $0 |
| Value of total assets at end of year | 2015-08-31 | $207,885,956 |
| Value of total assets at beginning of year | 2015-08-31 | $144,214,721 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-08-31 | $48,490 |
| Total interest from all sources | 2015-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2015-08-31 | $492,703 |
| Administrative expenses professional fees incurred | 2015-08-31 | $48,490 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2015-08-31 | $110,976 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2015-08-31 | $68,744 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2015-08-31 | $28,254 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2015-08-31 | $26,598 |
| Total non interest bearing cash at end of year | 2015-08-31 | $0 |
| Value of net income/loss | 2015-08-31 | $52,950,367 |
| Value of net assets at end of year (total assets less liabilities) | 2015-08-31 | $207,857,702 |
| Value of net assets at beginning of year (total assets less liabilities) | 2015-08-31 | $144,188,123 |
| Value of interest in common/collective trusts at end of year | 2015-08-31 | $18,735,903 |
| Value of interest in common/collective trusts at beginning of year | 2015-08-31 | $8,205,673 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-08-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2015-08-31 | $16,726 |
| Income. Dividends from common stock | 2015-08-31 | $492,703 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2015-08-31 | $189,039,077 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2015-08-31 | $135,940,304 |
| Aggregate proceeds on sale of assets | 2015-08-31 | $50,271,933 |
| Aggregate carrying amount (costs) on sale of assets | 2015-08-31 | $36,924,211 |
| 2014 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2014 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2014-08-31 | $34,184,435 |
| Total unrealized appreciation/depreciation of assets | 2014-08-31 | $34,184,435 |
| Total transfer of assets to this plan | 2014-08-31 | $7,143,443 |
| Total transfer of assets from this plan | 2014-08-31 | $30,023,561 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-08-31 | $26,598 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-08-31 | $20,333 |
| Total income from all sources (including contributions) | 2014-08-31 | $45,959,349 |
| Total loss/gain on sale of assets | 2014-08-31 | $11,524,895 |
| Total of all expenses incurred | 2014-08-31 | $47,335 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-08-31 | $0 |
| Value of total assets at end of year | 2014-08-31 | $144,214,721 |
| Value of total assets at beginning of year | 2014-08-31 | $121,176,560 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-08-31 | $47,335 |
| Total interest from all sources | 2014-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2014-08-31 | $242,372 |
| Administrative expenses professional fees incurred | 2014-08-31 | $47,335 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2014-08-31 | $68,744 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2014-08-31 | $26,118 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2014-08-31 | $26,598 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2014-08-31 | $20,333 |
| Value of net income/loss | 2014-08-31 | $45,912,014 |
| Value of net assets at end of year (total assets less liabilities) | 2014-08-31 | $144,188,123 |
| Value of net assets at beginning of year (total assets less liabilities) | 2014-08-31 | $121,156,227 |
| Value of interest in common/collective trusts at end of year | 2014-08-31 | $8,205,673 |
| Value of interest in common/collective trusts at beginning of year | 2014-08-31 | $14,180,772 |
| Net investment gain or loss from common/collective trusts | 2014-08-31 | $7,647 |
| Income. Dividends from common stock | 2014-08-31 | $242,372 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2014-08-31 | $135,940,304 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2014-08-31 | $106,969,670 |
| Aggregate proceeds on sale of assets | 2014-08-31 | $51,002,222 |
| Aggregate carrying amount (costs) on sale of assets | 2014-08-31 | $39,477,327 |
| 2013 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2013 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2013-08-31 | $36,409,139 |
| Total unrealized appreciation/depreciation of assets | 2013-08-31 | $36,409,139 |
| Total transfer of assets to this plan | 2013-08-31 | $6,625,678 |
| Total transfer of assets from this plan | 2013-08-31 | $6,330,572 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-08-31 | $20,333 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-08-31 | $19,195 |
| Total income from all sources (including contributions) | 2013-08-31 | $40,681,130 |
| Total loss/gain on sale of assets | 2013-08-31 | $4,020,279 |
| Total of all expenses incurred | 2013-08-31 | $40,705 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-08-31 | $0 |
| Value of total assets at end of year | 2013-08-31 | $121,176,560 |
| Value of total assets at beginning of year | 2013-08-31 | $80,239,891 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-08-31 | $40,705 |
| Total interest from all sources | 2013-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2013-08-31 | $242,883 |
| Administrative expenses professional fees incurred | 2013-08-31 | $40,705 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2013-08-31 | $26,118 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2013-08-31 | $18,415 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2013-08-31 | $20,333 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2013-08-31 | $19,195 |
| Value of net income/loss | 2013-08-31 | $40,640,425 |
| Value of net assets at end of year (total assets less liabilities) | 2013-08-31 | $121,156,227 |
| Value of net assets at beginning of year (total assets less liabilities) | 2013-08-31 | $80,220,696 |
| Value of interest in common/collective trusts at end of year | 2013-08-31 | $14,180,772 |
| Value of interest in common/collective trusts at beginning of year | 2013-08-31 | $6,797,653 |
| Net investment gain or loss from common/collective trusts | 2013-08-31 | $8,829 |
| Income. Dividends from common stock | 2013-08-31 | $242,883 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2013-08-31 | $106,969,670 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2013-08-31 | $73,423,823 |
| Aggregate proceeds on sale of assets | 2013-08-31 | $38,748,858 |
| Aggregate carrying amount (costs) on sale of assets | 2013-08-31 | $34,728,579 |
| 2012 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2012 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2012-08-31 | $12,510,283 |
| Total unrealized appreciation/depreciation of assets | 2012-08-31 | $12,510,283 |
| Total transfer of assets to this plan | 2012-08-31 | $14,058,488 |
| Total transfer of assets from this plan | 2012-08-31 | $39,241,384 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-08-31 | $19,195 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-08-31 | $184,761 |
| Total income from all sources (including contributions) | 2012-08-31 | $29,489,189 |
| Total loss/gain on sale of assets | 2012-08-31 | $16,830,183 |
| Total of all expenses incurred | 2012-08-31 | $39,711 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-08-31 | $0 |
| Value of total assets at end of year | 2012-08-31 | $80,239,891 |
| Value of total assets at beginning of year | 2012-08-31 | $76,138,875 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-08-31 | $39,711 |
| Total interest from all sources | 2012-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2012-08-31 | $136,542 |
| Administrative expenses professional fees incurred | 2012-08-31 | $39,711 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2012-08-31 | $18,415 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2012-08-31 | $2,257,859 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2012-08-31 | $19,195 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2012-08-31 | $184,761 |
| Total non interest bearing cash at beginning of year | 2012-08-31 | $0 |
| Value of net income/loss | 2012-08-31 | $29,449,478 |
| Value of net assets at end of year (total assets less liabilities) | 2012-08-31 | $80,220,696 |
| Value of net assets at beginning of year (total assets less liabilities) | 2012-08-31 | $75,954,114 |
| Value of interest in common/collective trusts at end of year | 2012-08-31 | $6,797,653 |
| Value of interest in common/collective trusts at beginning of year | 2012-08-31 | $4,012,756 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2012-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2012-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2012-08-31 | $12,181 |
| Income. Dividends from common stock | 2012-08-31 | $136,542 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2012-08-31 | $73,423,823 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2012-08-31 | $69,868,260 |
| Aggregate proceeds on sale of assets | 2012-08-31 | $50,161,986 |
| Aggregate carrying amount (costs) on sale of assets | 2012-08-31 | $33,331,803 |
| 2011 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2011 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2011-08-31 | $12,972,053 |
| Total unrealized appreciation/depreciation of assets | 2011-08-31 | $12,972,053 |
| Total transfer of assets to this plan | 2011-08-31 | $1,424,031 |
| Total transfer of assets from this plan | 2011-08-31 | $8,118,441 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-08-31 | $184,761 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-08-31 | $41,939 |
| Total income from all sources (including contributions) | 2011-08-31 | $18,130,221 |
| Total loss/gain on sale of assets | 2011-08-31 | $5,063,715 |
| Total of all expenses incurred | 2011-08-31 | $35,340 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-08-31 | $0 |
| Value of total assets at end of year | 2011-08-31 | $76,138,875 |
| Value of total assets at beginning of year | 2011-08-31 | $64,595,582 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-08-31 | $35,340 |
| Total interest from all sources | 2011-08-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2011-08-31 | $80,918 |
| Administrative expenses professional fees incurred | 2011-08-31 | $35,340 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2011-08-31 | $2,257,859 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2011-08-31 | $1,541 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2011-08-31 | $184,761 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2011-08-31 | $41,939 |
| Total non interest bearing cash at end of year | 2011-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2011-08-31 | $0 |
| Value of net income/loss | 2011-08-31 | $18,094,881 |
| Value of net assets at end of year (total assets less liabilities) | 2011-08-31 | $75,954,114 |
| Value of net assets at beginning of year (total assets less liabilities) | 2011-08-31 | $64,553,643 |
| Value of interest in common/collective trusts at end of year | 2011-08-31 | $4,012,756 |
| Value of interest in common/collective trusts at beginning of year | 2011-08-31 | $2,153,295 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2011-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2011-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2011-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2011-08-31 | $13,535 |
| Income. Dividends from common stock | 2011-08-31 | $80,918 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2011-08-31 | $8,431 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2011-08-31 | $69,868,260 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2011-08-31 | $62,432,315 |
| Aggregate proceeds on sale of assets | 2011-08-31 | $31,762,973 |
| Aggregate carrying amount (costs) on sale of assets | 2011-08-31 | $26,699,258 |
| 2010 : WTC-CIF BIOTECHNOLOGY PORTFOLIO 2010 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2010-08-31 | $-897,808 |
| Total unrealized appreciation/depreciation of assets | 2010-08-31 | $-897,808 |
| Total transfer of assets to this plan | 2010-08-31 | $1,278,734 |
| Total transfer of assets from this plan | 2010-08-31 | $10,678,552 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-08-31 | $41,939 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-08-31 | $21,312 |
| Total income from all sources (including contributions) | 2010-08-31 | $4,903,707 |
| Total loss/gain on sale of assets | 2010-08-31 | $898,038 |
| Total of all expenses incurred | 2010-08-31 | $35,379 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-08-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-08-31 | $0 |
| Value of total assets at end of year | 2010-08-31 | $64,595,582 |
| Value of total assets at beginning of year | 2010-08-31 | $69,106,445 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-08-31 | $35,379 |
| Total interest from all sources | 2010-08-31 | $47 |
| Total dividends received (eg from common stock, registered investment company shares) | 2010-08-31 | $344,588 |
| Administrative expenses professional fees incurred | 2010-08-31 | $35,379 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2010-08-31 | $1,541 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2010-08-31 | $1,377 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2010-08-31 | $41,939 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2010-08-31 | $21,312 |
| Total non interest bearing cash at end of year | 2010-08-31 | $0 |
| Total non interest bearing cash at beginning of year | 2010-08-31 | $2,237,888 |
| Value of net income/loss | 2010-08-31 | $4,868,328 |
| Value of net assets at end of year (total assets less liabilities) | 2010-08-31 | $64,553,643 |
| Value of net assets at beginning of year (total assets less liabilities) | 2010-08-31 | $69,085,133 |
| Income. Interest from corporate debt instruments | 2010-08-31 | $47 |
| Value of interest in common/collective trusts at end of year | 2010-08-31 | $2,153,295 |
| Value of interest in common/collective trusts at beginning of year | 2010-08-31 | $3,820,404 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2010-08-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2010-08-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2010-08-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2010-08-31 | $4,558,842 |
| Income. Dividends from common stock | 2010-08-31 | $344,588 |
| Asset. Corporate debt instrument debt (other) at end of year | 2010-08-31 | $8,431 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2010-08-31 | $62,432,315 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2010-08-31 | $63,046,776 |
| Aggregate proceeds on sale of assets | 2010-08-31 | $230 |
| Aggregate carrying amount (costs) on sale of assets | 2010-08-31 | $-897,808 |
